Paul M. Ossenkoppele

628 citations

14 papers · 441 indexed · h-index 10

Co-authors: M.D. Njoo E.M.G.J. de Jong M.I.A. Koetsier J.M. Mommers Wietske Kievit P.C.M. van de Kerkhof Marisol E. Otero W.P. Arnold
Topics: Psoriasis: Treatment and Pathogenesis (11 papers)Dermatology and Skin Diseases (7 papers)Health Systems, Economic Evaluations, Quality of Life (5 papers)
Cited by: Dermatology Immunology Microbiology
Journals: SHILAP Revista de lepidopterologíaJournal of Clinical Microbiology British Journal of Dermatology
Partner nations: Netherlands United States

In The Last Decade

Paul M. Ossenkoppele

11 papers receiving 436 citations

Peers

Countries citing papers authored by Paul M. Ossenkoppele

Since Specialization

Citations

This map shows the geographic impact of Paul M. Ossenkoppele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Ossenkoppele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Ossenkoppele more than expected).

Fields of papers citing papers by Paul M. Ossenkoppele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Ossenkoppele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Ossenkoppele. The network helps show where Paul M. Ossenkoppele may publish in the future.

Co-authorship network of co-authors of Paul M. Ossenkoppele

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Ossenkoppele. A scholar is included among the top collaborators of Paul M. Ossenkoppele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Ossenkoppele. Paul M. Ossenkoppele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Revealing patient characteristics and treatment outcomes among ultra-long users of biologics for psoriasis 2024 ·Clinical and Experimental Dermatology ·(unknown),Marisol E. Otero,J. M. P. A. van den Reek,E.M.G.J. de Jong,(unknown),R.R.M.C. Keijsers,P.P.M. van Lümig,Paul M. Ossenkoppele,Inge Haeck,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),A.M. Oostveen,Bas Peters,J.M. Mommers,Martijn B. A. van Doorn,Milan Tjioe,W.P. Arnold,(unknown),Marloes M. Kleinpenning	0
2	Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial 2022 ·Journal of Dermatological Treatment ·(unknown),Sophie E. Berends,Hans Groenewoud,Ron A. A. Mathôt,(unknown),J.M. Mommers,Paul M. Ossenkoppele,M.I.A. Koetsier,M.A.M. Berends,Annick de Vries,P.C.M. van de Kerkhof,Alfons A den Broeder,E.M.G.J. de Jong,J. M. P. A. van den Reek	8
3	[Granuloma annulare after herpes zoster: Wolf's isotopic response]. 2021 ·PubMed ·(unknown),(unknown),Paul M. Ossenkoppele,(unknown),(unknown)	0
4	A Case of Hypercalcemia in an Immunocompetent Patient with Disseminated Mycobacterium marinum Infection with a Rain Barrel as the Most Likely Primary Source 2021 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Folkert W. Visser,Paul M. Ossenkoppele,(unknown),(unknown)	0
5	Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study 2020 ·Acta Dermato Venereologica ·(unknown),J.M.P.A. van den Reek,Marisol E. Otero,M.D. Njoo,J.M. Mommers,Paul M. Ossenkoppele,M.I.A. Koetsier,(unknown),P.C.M. van de Kerkhof,Hans Groenewoud,Alfons A den Broeder,E.M.G.J. de Jong,Wietske Kievit	12
6	Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis 2020 ·JAMA Dermatology ·(unknown),J.M.P.A. van den Reek,Alfons A den Broeder,Lieke J. van Vugt,Marisol E. Otero,M.D. Njoo,J.M. Mommers,Paul M. Ossenkoppele,M.I.A. Koetsier,M.A.M. Berends,P.C.M. van de Kerkhof,Hans Groenewoud,Wietske Kievit,E.M.G.J. de Jong	34
7	Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry 2019 ·Journal of the European Academy of Dermatology and Venereology ·(unknown),J.M.P.A. van den Reek,J.M.M. Groenewoud,Marisol E. Otero,M.D. Njoo,Paul M. Ossenkoppele,J.M. Mommers,M.I.A. Koetsier,M.A.M. Berends,W.P. Arnold,B Peters,M.P.M. Andriessen,(unknown),A.L.A. Kuijpers,E.M.G.J. de Jong	33
8	Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study 2018 ·Acta Dermato Venereologica ·J.M.P.A. van den Reek,Lieke J. van Vugt,Martijn B. A. van Doorn,G. E. van der Kraaij,W.J. Kort,G.P.H. Lucker,Barbara Horváth,M.D. Njoo,(unknown),Paul M. Ossenkoppele,Marjolein de Bruin‐Weller,M. de Groot,(unknown),(unknown),P.C.M. van de Kerkhof,Phyllis I. Spuls,Wietske Kievit,E.M.G.J. de Jong	48
9	Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t 2016 ·British Journal of Dermatology ·Jeffrey Zweegers,J.M.P.A. van den Reek,P.C.M. van de Kerkhof,Marisol E. Otero,A.L.A. Kuijpers,M.I.A. Koetsier,W.P. Arnold,M.A.M. Berends,(unknown),Paul M. Ossenkoppele,M.D. Njoo,J.M. Mommers,P.P.M. van Lümig,R.J.B. Driessen,Wietske Kievit,E.M.G.J. de Jong	60
10	Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry 2016 ·British Journal of Dermatology ·Jeffrey Zweegers,J.M.M. Groenewoud,J. M. P. A. van den Reek,Marisol E. Otero,P.C.M. van de Kerkhof,R.J.B. Driessen,P.P.M. van Lümig,M.D. Njoo,Paul M. Ossenkoppele,J.M. Mommers,M.I.A. Koetsier,W.P. Arnold,M.P.M. Andriessen,A.L.A. Kuijpers,M.A.M. Berends,Wietske Kievit,E.M.G.J. de Jong	38
11	Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network 2014 ·British Journal of Dermatology ·J.M.P.A. van den Reek,(unknown),Marisol E. Otero,Jeffrey Zweegers,P.C.M. van de Kerkhof,Paul M. Ossenkoppele,M.D. Njoo,J.M. Mommers,M.I.A. Koetsier,W.P. Arnold,(unknown),A.L.A. Kuijpers,M.P.M. Andriessen,Marieke M.B. Seyger,Wietske Kievit,E.M.G.J. de Jong	24
12	‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTUREnetwork 2014 ·British Journal of Dermatology ·J. M. P. A. van den Reek,Jeffrey Zweegers,Wietske Kievit,Marisol E. Otero,P.P.M. van Lümig,R.J.B. Driessen,Paul M. Ossenkoppele,M.D. Njoo,J.M. Mommers,M.I.A. Koetsier,W.P. Arnold,(unknown),A.L.A. Kuijpers,M.P.M. Andriessen,P.C.M. van de Kerkhof,Marieke M.B. Seyger,E.M.G.J. de Jong	77
13	Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: Bio CAPTURE 2014 ·British Journal of Dermatology ·Jeffrey Zweegers,J. M. P. A. van den Reek,(unknown),Marisol E. Otero,Paul M. Ossenkoppele,M.D. Njoo,J.M. Mommers,M.I.A. Koetsier,W.P. Arnold,(unknown),A.L.A. Kuijpers,M.P.M. Andriessen,Wietske Kievit,E.M.G.J. de Jong	19
14	Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis 1992 ·Journal of Clinical Microbiology ·J M Ossewaarde,(unknown),M. Rozenberg-Arska,Paul M. Ossenkoppele,(unknown),Anton M. van Loon	88

About Paul M. Ossenkoppele

Paul M. Ossenkoppele is a scholar working on Dermatology, Immunology and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 441 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). The work is most often cited by research in Dermatology (171 citations), Immunology (316 citations) and Microbiology (81 citations). Paul M. Ossenkoppele has collaborated with scholars based in Netherlands and United States. Frequent co-authors include M.D. Njoo, E.M.G.J. de Jong, M.I.A. Koetsier, J.M. Mommers, Wietske Kievit, P.C.M. van de Kerkhof, Marisol E. Otero, W.P. Arnold, A.L.A. Kuijpers and J M Ossewaarde. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact